Jennifer graduated from the University of Basel in April 2016 with a MSc in Pharmaceutical Sciences. She conducted her Master thesis «Successful lead optimization of a potential Siglec-8 agonist – Exploiting a deoxygenation strategy» in the group of Prof. Dr. Beat Ernst.

In October 2016, she joined the group of Prof. Dr. Karl-Heinz Altmann as a PhD student. Her NCCR TransCure project is focused on the development of novel SLC7A5 ligands as potential antitumor agents.

Website: Group Altmann

E-Mail:
jennifer.mueller@pharma.ethz.ch